Bladder Cancer - Results from #360

The Impact of Histologic Subtypes on Clinical Outcomes After Radiation-Based Therapy for Muscle-Invasive Bladder Cancer. July 27, 2024

Adaptive radiotherapy for muscle invasive bladder cancer: a retrospective audit of two bladder filling protocols. July 26, 2024

Prospective Comparison of 2D and 3D T2-Weighted Imaging in Multiparametric MRI for Assessing Muscle Invasion Accuracy Using VI-RADS in Bladder Cancer. July 26, 2024

The role of VI-RADS scoring criteria for predicting oncological outcomes in bladder cancer. July 26, 2024

Photodynamic Therapeutic Effect during 5-Aminolevulinic Acid-Mediated Photodynamic Diagnosis-Assisted Transurethral Resection of Bladder Tumors July 25, 2024

A Urinary Biomarker to Triage Patients for Cystoscopy in Patients with Microhematuria - Expert Commentary July 25, 2024

Fibroblast Activation Protein-α and the Immune Landscape: Unraveling T1 Non-muscle-invasive Bladder Cancer Progression. July 25, 2024

A Podcast on Practical Considerations in Patients with Advanced Urothelial Cancer Receiving First-Line Cisplatin- or Carboplatin-Based Chemotherapy Followed by Avelumab Maintenance in a Changing Therapeutic Landscape. July 25, 2024

Epirubicin and Non-Muscle Invasive Bladder Cancer Treatment: A Systematic Review. July 24, 2024

The Development of a Video-based Nutrition Education Curriculum for Patients Undergoing Radical Cystectomy. July 24, 2024

Novel Delivery Mechanisms for Existing Systemic Agents and Emerging Therapies in Bladder Cancer. July 24, 2024

The Effects of circPKN2 on Ferroptosis in Bladder Cancer - Expert Commentary July 23, 2024

Phase 3 THOR Japanese subgroup analysis: erdafitinib in advanced or metastatic urothelial cancer and fibroblast growth factor receptor alterations. July 23, 2024

Incidence, Characteristics and Survival Rates of Bladder Cancer after Rectosigmoid Cancer Radiation. July 23, 2024

Impact of Angiotensin Converting Enzyme Inhibitors on Pathologic Complete Response With Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer. July 23, 2024

Plasma-Derived Cell-Free DNA as a Biomarker for Early Detection, Prognostication, and Personalized Treatment of Urothelial Carcinoma. July 23, 2024

CircPKN2 promotes ferroptosis in bladder cancer by promoting the ubiquitination of Stearoyl-CoA Desaturase 1. July 22, 2024

Correlative Analysis of ATM, RB1, ERCC2, and FANCC Mutations and Pathologic Complete Response After Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer: Results from the SWOG S1314 Trial. July 22, 2024

Survival of Metastatic Urothelial Carcinoma of Urinary Bladder According to Number and Location of Visceral Metastases. July 22, 2024

Trends and Disparities in Next-Generation Sequencing in Metastatic Prostate and Urothelial Cancers. July 22, 2024

Page 19 of 525